Optimizing Outpatient Care: Clinical Strategies for Managing Hepatic Encephalopathy in Primary Practice : Episode 12

Opinion

Video

Published: July 15, 2024 | Updated: July 15, 2024

Refractory Encephalopathy, Multivitamins and Closing Thoughts

Author(s):

Pamela Kushner, MD, FAAFP ,Nancy Reau, MD

Medical experts share insights on managing refractory hepatic encephalopathy and provide concluding remarks and essential points on the condition.

EP: 1.Exploring the Impact of Hepatic Encephalopathy on Patients and Their Families

EP: 2.Educating Primary Care Clinicians on Outpatient HE Management and Ammonia Testing

EP: 3.HE Experts on Symptoms, Risk Factors, Diagnosis Challenges, and Severity Grading

EP: 4.Collaborating with Specialists: Primary Care Clinician’s Evolving Role in HE Management

EP: 5.Preventing Cirrhosis Progression: Gut-Liver Axis, Circulation, Inflammation

EP: 6.Hepatic Encephalopathy: Exploring Alterations in Microbiota Caused by Liver Disease

EP: 7.Current Hepatic Encephalopathy Therapies Targeting Gut-Liver Axis Disturbance

EP: 8.AASLD Guidelines for Hepatic Encephalopathy: Rifaximin's Role and Safety

EP: 9.Overview of Outpatient Strategies for Optimizing Patient Outcomes in HE

EP: 10.Managing Adverse Effects in HE Treatment

EP: 11.Practical Tips for the Primary Care Clinician Treating HE

EP: 12.Refractory Encephalopathy, Multivitamins and Closing Thoughts

What is the recommendation on multivitamins and supplements in patients with chronic liver disease?
How frequent is refractory encephalopathy?

Related Videos

Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD

Aflibercept 8 mg Shows Durability at 3 Years in Wet AMD with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center

Investigating Brensocatib, Potential First Treatment for Bronchiectasis, with James Chalmers, MBChB, PhD

Aflibercept 8 mg Noninferior for RVO in QUASAR with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center

AI in Dermatology: Emerging Insights and Diverging Perspectives

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.